Researchers in China examined middle-aged male monkeys and found that those given a daily dose of metformin over three years ...

After SARS-CoV-2 infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute sequalae of SARS-CoV-2.

A new study finds Metformin, a popular diabetes drug, may slow aging. WBZ-TV's Dr. Mallika Marshall reports. In this slot ...

Dr. Crystal Aguh, a doctor at Johns Hopkins Medicine, is now using a diabetes medicine named metformin to combat hair loss in ...

USA: The results of the FOREMOST trial indicate that apremilast is effective for patients with early psoriatic arthritis (PsA ...

An updated version of the 2015 trial is adding the older diabetes drug metformin to see if the results are even stronger.

The appellation “wonder drug” might even be an understatement, reckons Harvard Health’s Robert Shmerling, MD. But why?

Retta revealed that she was diagnosed with type 2 diabetes in July 2023, admitting that she “never thought” about the chronic ...

Contemporary healthcare seeks to minimize complications, expedite recovery, and improve prognoses, prompting the integration ...

The science of ageing is a captivating field. Researchers are exploring the roles of senescent cells, their signalling ...

SGLT2 inhibitors and dulaglutide are associated with comparable risk for dementia; however, it is uncertain whether these findings generalize to newer GLP-1 RAs.

The 13 drugs most likely to be chosen for CMS negotiations, according to the study: Ozempic, Rybelsus and Wegovy (semaglutide): Novo Nordisk's treatment for Type 2 diabetes and weight management.